Antibodies against
View Patent ↗Antibodies that specifically bind to toxins of C. difficile , antigen binding portions thereof, and methods of making and using the antibodies and antigen binding portions thereof are provided herein.
1. A composition comprising a first monoclonal antibody, or an antigen binding portion thereof, and a second monoclonal antibody, or an antigen binding portion thereof, wherein,
(a) the first antibody, or antigen binding portion thereof, comprises a heavy and light chain variable region having the amino acid sequences set forth in SEQ ID NOs:1 and 4, respectively, and
(b) the second antibody, or antigen binding portion thereof, comprises a heavy and light chain variable region having the amino acid sequences set forth in SEQ ID NOs:54 and 58, respectively.
2. The composition of claim 1 , wherein the first or second antibody is a human antibody, a humanized antibody or a chimeric antibody.
3. The composition of claim 1 , wherein the antigen binding portion of the first or second antibody is a Fab, Fab′2, ScFv, Fd, Fv or dAb.
4. The composition of claim 1 , wherein the K D of the first or second antibody, or antigen binding portion thereof, is less than 20×10 −6 M.